Drug-Intake Regulation and the Interplay between Economic Costs and Benefits
Originally published by the American Psychological Association.
This article may not exactly replicate the final version published in the APA journal. It is not the copy of record.
Publisher's PDF available for purchase through remote link.
Note: Greg Madden was affiliated with the University of Wisconsin at time of publication.
W. J. Lynch and M. E. Carroll's (see record 2001-06653-001) review argues aversive effects and for satiation and direct effects as the mechanisms responsible for the descending limb of the dose-response function. Analysis is provided that suggests they may prematurely dispose of the aversive-effects account. Further analysis of the evidence for satiation and direct effects supports the authors' contention that neither can be exclusively supported. A brief behavioral–economic analysis of drug-intake regulation and the descending limb of the dose-response function is presented.
Madden, G. J. (2001). Drug-intake regulation and the interplay between economic costs and benefits. Experimental and Clinical Psychopharmacology, 9, 148-150.